Where does Wave Life Sciences Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Wave Life Sciences Ltd. ranks #9,929 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Wave Life Sciences Ltd. hold?

Wave Life Sciences Ltd. holds 32 US utility patents granted between 2017 and 2025, spanning 10 technology areas.

What is Wave Life Sciences Ltd.'s Innovation Score?

Wave Life Sciences Ltd. has an Innovation Score of 41.9 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Wave Life Sciences Ltd. focus on?

Wave Life Sciences Ltd.'s top technology area is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids) with 23 patents, ranking #24 of 896 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Wave Life Sciences Ltd.'s patent grant rate increasing or decreasing?

Wave Life Sciences Ltd.'s recent grant velocity is +42% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Wave Life Sciences Ltd.'s patents?

Wave Life Sciences Ltd.'s patents average 21.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Wave Life Sciences Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Wave Life Sciences Ltd.

USPTO PatentsView assignee record - 32 granted patents across 10 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Wave ranks #9,929 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 10 technology areas.

#9,929
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 21.7
avg claims per patent: +42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9929 · Foreign Corporation #9,929 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 32 grants
UPPER-Q #9,929/49,997
PHOTO-FINISH Verizon and Redbox…
CPC-FOCUS C07H · 10 areas
INNOV-PAR 41.9/100
CLAIMS-DENSE 21.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +42% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Verizon and Redbox Digital Entertainment Services, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Wave’s 41.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.1 pts (29%) Velocity 5.6 pts (13%) Breadth 11.2 pts (27%) Claim depth 13.0 pts (31%)

Qualcomm Incorporated · highest

85
Amesbury Group · near

42
ShelterLogic · near

42
Uhnder · near

42
Vanderlande… · near

42
Wave Life Sciences · this assignee

42
3D Lighting… · lowest

7

What this shows Wave's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Wave?

Each dot is one of Wave’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Wave’s own 21.7 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Wave vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Wave's grants concentrate

Wave Life Sciences Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 71.9% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2022. By volume, Wave sits between Verizon and Redbox Digital Entertainment Services, LLC and Willow Innovations, Inc..

Wave's three-year grant acceleration

Wave Life Sciences Ltd. shows 11 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Verizon and Redbo…

32
Vilnius University

32
Vulcan Industrial…

32
Vyaire Medical

32
Webasto-edscha Ca…

32
WET

32
Weatherford U K

32
Willow Innovations

32
Wave Life Sciences ◀

32

What this shows Wave holds 32 patents at rank #9,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Wave

By rank, the assignees closest to #9,928 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in Wave's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Wave, neither rank-band nor same-CPC leaders (those blocks stay above). In C07H (Sugars), Wave ranks #24 of 896 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

ShelterLogic Corp. 42 Vanderlande Industries B.V. 42 Amesbury Group, Inc. 42 Uhnder, Inc. 42

Wave's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Wave Life Sciences Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	6.3%
2018	3	9.4%
2019	7	21.9%
2020	4	12.5%
2021	2	6.3%
2022	1	3.1%
2023	8	25.0%
2024	2	6.3%
2025partial year	3	9.4%

Which technologies does Wave Life Sciences Ltd. patent most?

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 23

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C07D - Heterocyclic Compounds 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 10

C07C - Acyclic OR Carbocyclic Compounds 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C12Y - Enzymes 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Wave Life Sciences Ltd.'s patent record in context - here's where to go next.

Wave Life Sciences Ltd.'s lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 71.9% of its portfolio - see every assignee active in that class. Explore C07H
Ranked #9,929 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Wave Life Sciences Ltd. against Verizon and Redbox Digital Entertainment Services, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.